3-hydroxyflavone has been researched along with Non-alcoholic Fatty Liver Disease in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 6 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Chen, L; Lin, S; Lyu, Q; Teng, H | 1 |
| Gong, H; Li, M; Xu, H; Zhang, D | 1 |
| Huang, S; Jin, R; Li, X; Tan, L; Tong, H; Zhang, X | 1 |
| Hua, YQ; Wang, W; Xu, XL; Zeng, Y; Zhang, H | 1 |
| Chen, K; He, X; Hou, DX; Sakao, K; Xie, K | 1 |
| Bi, Y; Chen, J; Fu, J; Liu, B; Wang, X; Xia, T; Zhu, R | 1 |
| Ji, H; Kim, JS; Kim, SJ; Lee, EO; Lee, HJ; Lee, SO | 1 |
| Guo, H; Guruvaiah, P; Li, D; Xie, Z | 1 |
| Chen, YL; Cheng, CY; Huang, WC; Liou, CJ; Wang, CL; Wei, CH | 1 |
| El-Horany, HE; Gaballah, HH; Helal, DS | 1 |
| Ho, CT; Lai, CS; Pan, MH; Tsai, ML | 1 |
| Chen, S; Gao, Y; Liu, P; Mi, M; Qin, Y; Ran, L; Shu, F; Wan, J; Wang, X; Zhang, Q; Zhang, Y; Zhao, X; Zhu, J | 1 |
4 review(s) available for 3-hydroxyflavone and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Molecular mechanism and therapeutic significance of dihydromyricetin in nonalcoholic fatty liver disease.
Topics: Flavonols; Humans; Lipid Metabolism; Liver; Non-alcoholic Fatty Liver Disease | 2022 |
Multitarget and promising role of dihydromyricetin in the treatment of metabolic diseases.
Topics: Animals; Atherosclerosis; Diabetes Mellitus; Flavonols; Gene Expression Regulation; Humans; Hypoglycemic Agents; Metabolic Diseases; Non-alcoholic Fatty Liver Disease; Osteoporosis; Signal Transduction | 2020 |
Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease.
Topics: Carcinoma, Hepatocellular; Flavonols; Humans; Liver Diseases; Liver Diseases, Alcoholic; Liver Failure, Acute; Liver Neoplasms; Liver Regeneration; Non-alcoholic Fatty Liver Disease; Protective Agents | 2021 |
Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.
Topics: Adipokines; Animals; Carotenoids; Curcumin; Fatty Acids, Omega-3; Fatty Liver; Flavonols; Humans; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Polyphenols; Resveratrol; Stilbenes | 2014 |
1 trial(s) available for 3-hydroxyflavone and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial.
Topics: Adult; Ampelopsis; Biomarkers; Double-Blind Method; Female; Flavonols; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Plants, Medicinal | 2015 |
7 other study(ies) available for 3-hydroxyflavone and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
A designed self-microemulsion delivery system for dihydromyricetin and its dietary intervention effect on high-fat-diet fed mice.
Topics: Animals; Diet, High-Fat; Flavonols; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease | 2022 |
Modulation of SIRT1-mediated signaling cascades in the liver contributes to the amelioration of nonalcoholic steatohepatitis in high fat fed middle-aged LDL receptor knockout mice by dihydromyricetin.
Topics: Age Factors; Animals; Cell Line, Transformed; Diet, High-Fat; Flavonols; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Receptors, LDL; Sirtuin 1 | 2020 |
Ameliorative effects and molecular mechanisms of vine tea on western diet-induced NAFLD.
Topics: AMP-Activated Protein Kinases; Ampelopsis; Animals; Antioxidants; Carnitine O-Palmitoyltransferase; Cytochrome P-450 CYP4A; Diet, High-Fat; Diet, Western; Drugs, Chinese Herbal; Flavonols; Gastrointestinal Microbiome; Hep G2 Cells; Humans; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Lipid Metabolism; Liver; Membrane Proteins; Mice, Inbred C57BL; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phytotherapy; PPAR alpha; Teas, Herbal | 2020 |
Comparison of the main components and bioactivity of Rhus verniciflua Stokes extracts by different detoxification processing methods.
Topics: Anti-Infective Agents; Antioxidants; Cell Line, Tumor; Cell Survival; Fermentation; Flavonoids; Flavonols; Humans; Lipogenesis; Models, Biological; Non-alcoholic Fatty Liver Disease; Phenols; Plant Extracts; Rhus | 2018 |
Preventive Effect of Flavonol Derivatives Abundant Sanglan Tea on Long-Term High-Fat-Diet-Induced Obesity Complications in C57BL/6 Mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Diet, High-Fat; Dietary Supplements; Flavonols; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Tea | 2018 |
Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Cell Line; Cell Survival; Diet, High-Fat; Fatty Acids; Flavonoids; Flavonols; Hepatocytes; Lipid Metabolism; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Protective Agents; Signal Transduction; Sirtuin 1 | 2018 |
Mitigative effects of the bioactive flavonol fisetin on high-fat/high-sucrose induced nonalcoholic fatty liver disease in rats.
Topics: Animals; Cell Cycle Proteins; Diet, High-Fat; Disease Models, Animal; Female; Flavonoids; Flavonols; Gene Expression Regulation; Hepatocyte Nuclear Factor 4; Non-alcoholic Fatty Liver Disease; Nuclear Proteins; Obesity; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Rats; Signal Transduction; Sucrose; Treatment Outcome | 2019 |